These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 7205848)

  • 21. Protein-calorie malnutrition and cutaneous anergy in hemodialysis maintained patients.
    Bansal VK; Popli S; Pickering J; Ing TS; Vertuno LL; Hano JE
    Am J Clin Nutr; 1980 Jul; 33(7):1608-11. PubMed ID: 6772014
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immune reactivity in head and neck squamous carcinoma and relevance to the design of immunotherapy trials.
    Browder JP; Chretien PB
    Semin Oncol; 1977 Dec; 4(4):431-9. PubMed ID: 339354
    [No Abstract]   [Full Text] [Related]  

  • 23. Delayed hypersensitivity in patients treated by curative radiotherapy. Its relation to tumor response and short-term survival.
    Bosworth JL; Ghossein NA; Brooks TL
    Cancer; 1975 Aug; 36(2):353-8. PubMed ID: 1157006
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Unique immunobiological aspects of head and neck squamous carcinoma.
    Chretien PB
    Can J Otolaryngol; 1975; 4(2):225-35. PubMed ID: 166742
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Delayed hypersensitivity and local control of patients treated by radiotherapy for head and neck cancer.
    Bosworth JL; Thaler S; Ghossein NA
    Am J Surg; 1976 Jul; 132(1):46-8. PubMed ID: 782265
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cellular immune competence and diarrheal morbidity in malnourished Bangladeshi children: a prospective field study.
    Koster FT; Palmer DL; Chakraborty J; Jackson T; Curlin GC
    Am J Clin Nutr; 1987 Jul; 46(1):115-20. PubMed ID: 3604962
    [TBL] [Abstract][Full Text] [Related]  

  • 27. T-cell deficiency in patients with squamous cell cancer of the head and neck.
    Wanebo HJ; Jun MY; Strong EW; Oettgen H
    Am J Surg; 1975 Oct; 130(4):445-51. PubMed ID: 1101724
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epstein-Barr virus (EBV) antibody in patients treated by radical radiotherapy for head and neck cancer.
    Halili MR; Spigland I; Foster N; Ghossein NA
    J Surg Oncol; 1978; 10(5):457-63. PubMed ID: 215844
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Delayed hypersensitivity reactions in patients with squamous cell cancer of the head and neck.
    Lundy J; Wanebo H; Pinsky C; Strong E; Oettgen H
    Am J Surg; 1974 Oct; 128(4):530-3. PubMed ID: 4429642
    [No Abstract]   [Full Text] [Related]  

  • 30. Effects of en bloc esophagectomy on nutritional and immune status in patients with esophageal carcinoma.
    Wang LS; Lin HY; Chang CJ; Fahn HJ; Huang MH; Lin CF
    J Surg Oncol; 1998 Feb; 67(2):90-8. PubMed ID: 9486779
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inferior outcomes in immunosuppressed patients with high-risk cutaneous squamous cell carcinoma of the head and neck treated with surgery and radiation therapy.
    Manyam BV; Gastman B; Zhang AY; Reddy CA; Burkey BB; Scharpf J; Alam DS; Fritz MA; Vidimos AT; Koyfman SA
    J Am Acad Dermatol; 2015 Aug; 73(2):221-7. PubMed ID: 26028524
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The doubtful relevance of nonspecific immune reactivity in patients with squamous cell carcinoma of the head and neck region.
    Bier J; Nicklisch U; Platz H
    Cancer; 1983 Oct; 52(7):1165-72. PubMed ID: 6603897
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preoperative nutritional support at home in head and neck cancer patients: from nutritional benefits to the prevention of the alcohol withdrawal syndrome.
    Bertrand PC; Piquet MA; Bordier I; Monnier P; Roulet M
    Curr Opin Clin Nutr Metab Care; 2002 Jul; 5(4):435-40. PubMed ID: 12107380
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A correlation between the histological parameters such as stromal reaction and cell-mediated immune-structure of the regional lymph nodes, and the delayed cutaneous hypersensitive reaction toward DNCB in cervical cancer (author's transl)].
    Obata N; Kodama S; Hando T; Hirogami T; Takeuchi S
    Nihon Sanka Fujinka Gakkai Zasshi; 1980 May; 32(5):550-8. PubMed ID: 7240843
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The value of the prognostic nutritional index in the management of patients with advanced carcinoma of the head and neck.
    Goodwin WJ; Torres J
    Head Neck Surg; 1984; 6(5):932-7. PubMed ID: 6427139
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunobiology of head and neck cancer: basic concepts.
    Wanebo HJ
    Head Neck Surg; 1979; 2(1):42-55. PubMed ID: 400659
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assays of immunocompetence in the staging and prognosis of cancer.
    Robinson JC
    Surg Gynecol Obstet; 1981 Dec; 153(6):909-21. PubMed ID: 7029761
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Abnormalities of quantitative dinitrochlorobenzene sensitization in cancer patients: correlation with tumor stage and histology.
    Catalona WJ; Chretien PB
    Cancer; 1973 Feb; 31(2):353-6. PubMed ID: 4687881
    [No Abstract]   [Full Text] [Related]  

  • 39. Delayed cutaneous hypersensitivity and peripheral lymphocyte counts in patients with advanced cancer.
    Lee YT; Sparks FC; Eilber FR; Morton DL
    Cancer; 1975 Mar; 35(3):748-55. PubMed ID: 1111942
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunologic evaluation of patients with advanced head and neck cancer receiving weekly chemoimmunotherapy.
    Zighelboim J; Dorey F; Parker NH; Calcaterra T; Ward P; Fahey JL
    Cancer; 1979 Jul; 44(1):117-23. PubMed ID: 313240
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.